These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12701950)

  • 1. The great escape? Prospects for regulating access to technology through health technology assessment.
    Johri M; Lehoux P
    Int J Technol Assess Health Care; 2003; 19(1):179-93. PubMed ID: 12701950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge mobilization in the context of health technology assessment: an exploratory case study.
    Fournier MF
    Health Res Policy Syst; 2012 Apr; 10():10. PubMed ID: 22472141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion and use of health technology assessment in policy making: what lessons for decentralised healthcare systems?
    Ciani O; Tarricone R; Torbica A
    Health Policy; 2012 Dec; 108(2-3):194-202. PubMed ID: 23093020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The which-hunt: assembling health technologies for assessment and rationing.
    Giacomini MK
    J Health Polit Policy Law; 1999 Aug; 24(4):715-58. PubMed ID: 10503155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modes of coordination for health technology adoption: Health Technology Assessment agencies and Group Procurement Organizations in a polycentric regulatory regime.
    Miller FA; Lehoux P; Rac VE; Bytautas JP; Krahn M; Peacock S
    Soc Sci Med; 2020 Nov; 265():113528. PubMed ID: 33261901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health technology assessment in Australia: a role for clinical registries?
    Scott AM
    Aust Health Rev; 2017 Mar; 41(1):19-25. PubMed ID: 27028134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technology assessment and the sociopolitics of health technologies.
    Lehoux P; Blume S
    J Health Polit Policy Law; 2000 Dec; 25(6):1083-120. PubMed ID: 11142053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHANGING HEALTH TECHNOLOGY ASSESSMENT PARADIGMS?
    Husereau D; Henshall C; Sampietro-Colom L; Thomas S
    Int J Technol Assess Health Care; 2016 Jan; 32(4):191-199. PubMed ID: 27766998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care cost containment: rationing medical technology.
    Nihom J; Gillpatrick TR; Wood VR
    J Ambul Care Mark; 1994; 5(2):57-68. PubMed ID: 10165484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
    Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
    Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective.
    Xie F; Bowen JM; Sutherland SC; Burke N; Blackhouse G; Tarride JE; O'Reilly D; Goeree R
    Expert Rev Pharmacoecon Outcomes Res; 2011 Oct; 11(5):513-21. PubMed ID: 21958096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ethical framework for rationing health care.
    Jecker NS; Pearlman RA
    J Med Philos; 1992 Feb; 17(1):79-96. PubMed ID: 1545186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steps toward improving ethical evaluation in health technology assessment: a proposed framework.
    Assasi N; Tarride JE; O'Reilly D; Schwartz L
    BMC Med Ethics; 2016 Jun; 17(1):34. PubMed ID: 27267369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AN INTEGRATED PERSPECTIVE ON THE ASSESSMENT OF TECHNOLOGIES: INTEGRATE-HTA.
    Wahlster P; Brereton L; Burns J; Hofmann B; Mozygemba K; Oortwijn W; Pfadenhauer L; Polus S; Rehfuess E; Schilling I; van der Wilt GJ; Gerhardus A
    Int J Technol Assess Health Care; 2017 Jan; 33(5):544-551. PubMed ID: 28756780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethics in Canadian health technology assessment: a descriptive review.
    DeJean D; Giacomini M; Schwartz L; Miller FA
    Int J Technol Assess Health Care; 2009 Oct; 25(4):463-9. PubMed ID: 19845976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prioritizing investments in health technology assessment. Can we assess potential value for money?
    Davies L; Drummond M; Papanikolaou P
    Int J Technol Assess Health Care; 2000; 16(1):73-91. PubMed ID: 10815355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.
    Laupacis A; Feeny D; Detsky AS; Tugwell PX
    CMAJ; 1992 Feb; 146(4):473-81. PubMed ID: 1306034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland.
    Allen N; Walker SR; Liberti L; Salek S
    Value Health; 2017 Mar; 20(3):320-328. PubMed ID: 28292476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
    Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.